Benzyl Bromide → 4-Benzyl-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid
反応式
C([O:3][C:4]([C:6]1([CH2:19][C:20]2[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=2)[CH2:11][CH2:10][N:9]([C:12]([O:14][C:15]([CH3:18])([CH3:17])[CH3:16])=[O:13])[CH2:8][CH2:7]1)=[O:5])C.C(Br)C1C=CC=CC=1.[OH-].[Na+].S([O-])(O)(=O)=O.[Na+]>C(O)C.O>[C:15]([O:14][C:12]([N:9]1[CH2:10][CH2:11][C:6]([CH2:19][C:20]2[CH:21]=[CH:22][CH:23]=[CH:24][CH:25]=2)([C:4]([OH:5])=[O:3])[CH2:7][CH2:8]1)=[O:13])([CH3:18])([CH3:16])[CH3:17]参加物
7
実験手順
N-tert-butyloxycarbonyl-4-benzylpiperidine-4-carboxylic acid ethyl ester (prepared as in Gilligan et al J. Med. Chem. 1994, 364-370 using benzyl bromide as the alkylating agent) (11.0 g; 32 mmol) was refluxed for 7 h. in a mixture of ethanol (190 ml) and aqueous sodium hydroxide (18% 190 ml). The volume was reduced to a third in vacuo and pH was adjusted to 3 with sodium hydrogen sulfate. Water (300 ml) was added and the mixture was extracted with ethylacetate (2×250 ml). The combined organic phases were evaporated to afford 8.6 g of N-tert-butyloxycarbonyl-4-benzylpiperidine-4-carboxylic acid.
後処理
- extractionthe mixture was extracted with ethylacetate (2×250 ml)
- customThe combined organic phases were evaporated
出典と根拠
- ORDレコード
- ord-744c36590e1e4c2daeb9181001ad04e3
- 出典データセット
- uspto-grants-2001_10
- 特許番号
- US06303620B1
反応ノート
読み込み中…